A novel biweekly multidrug regimen of gemcitabine, oxaliplatin, 5-fluorouracil (5-FU), and folinic acid (FA) in pretreated patients with advanced colorectal carcinoma.
In: British Journal of Cancer, Jg. 90 (2004-05-04), Heft 9, S. 1710-1714
Online
academicJournal
Zugriff:
Previous results suggest that GEM affects 5-fluorouracil (5-FU) metabolism and pharmacokinetics in cancer patients, while combined with oxaliplatin, levo-folinic acid, and 5-FU (GOLF regimen), at doses achievable in cancer patients, determines high cytotoxic and proapoptotic antitumour activity in colon cancer cells in vitro. On these bases we designed a phase I-II clinical trial testing the GOLF regimen in patients with metastatic colorectal carcinoma, who had received at least a prior line of chemotherapy. In total, 29 patients (20 males and nine females) enrolled in the study received every 2 weeks, gemcitabine (patients #1-3 received 600?mg?m -2 ; patients # 4-6 received 850?mg?m -2 ; while patients # 7-29 received 1000?mg?m -2 ) on the day 1, levo-folinic acid (100?mg?m -2 ) on the days 1 and 2; 5-fluorouracil (400?mg?m -2 ) in bolus injection, followed by a 22-h continuous infusion (800?mg?m -2 ) on the days 1 and 2, and oxaliplatin (85?mg?m -2 ), 6?h after the 5-FU bolus on day 2. The most frequent side effect was grade I-II haematological toxicity. In total, 28 patients were evaluable for response: three achieved a complete response, nine a partial response, 10 had a stable disease, and six progressed. The average time to progression and overall survival of the patients was, respectively, 7.26 and 22 months. Our GOLF combination is well tolerated and seems promising for the treatment of advanced colorectal cancer.British Journal of Cancer (2004) 90, 1710-1714. doi:10.1038/sj.bjc.6601783 www.bjcancer.com Published online 13 April 2004 [ABSTRACT FROM AUTHOR]
Copyright of British Journal of Cancer is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
A novel biweekly multidrug regimen of gemcitabine, oxaliplatin, 5-fluorouracil (5-FU), and folinic acid (FA) in pretreated patients with advanced colorectal carcinoma.
|
---|---|
Autor/in / Beteiligte Person: | Correale, P. ; Messinese, S. ; Caraglia, M. ; Marsili, S. ; Piccolomini, A. ; Petrioli, R. ; Ceciarini, F. ; Micheli, L. ; Nencuni, C. ; Neru, A. ; Vuolo, G. ; Guarnieri, A. ; Abbruzzese, A. ; Prete, S. D. ; Guorgu, G. ; Francunu, G. |
Link: | |
Zeitschrift: | British Journal of Cancer, Jg. 90 (2004-05-04), Heft 9, S. 1710-1714 |
Veröffentlichung: | 2004 |
Medientyp: | academicJournal |
ISSN: | 0007-0920 (print) |
DOI: | 10.1038/sj.bjc.6601783 |
Schlagwort: |
|
Sonstiges: |
|